ArticleJournal of experimental & clinical cancer research : CR2017

Annexin A2 contributes to cisplatin resistance by activation of JNK-p53 pathway in non-small cell lung cancer cells.

Xiaomin Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.